Profile
Göran Tornling currently works at AcuCort AB, as Independent Director from 2021, Karolinska Institutet, as Associate Professor, Biolipox AB, as Chief Medical Officer & Vice President from 2006, and AnaMar AB, as Chief Medical Officer.
Dr. Tornling also formerly worked at AstraZeneca R&D Boston, Inc., as Director-Medical Science.
Dr. Tornling received his doctorate degree from Karolinska Institutet.
Göran Tornling active positions
| Companies | Position | Start |
|---|---|---|
| ACUCORT AB | Director/Board Member | 2020-12-31 |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Chief Tech/Sci/R&D Officer | 2006-08-31 |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Chief Tech/Sci/R&D Officer | - |
Former positions of Göran Tornling
| Companies | Position | End |
|---|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Corporate Officer/Principal | - |
Training of Göran Tornling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Health Technology |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Health Technology |
AcuCort AB
AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
- Stock Market
- Insiders
- Göran Tornling
















